Surgical margin status and role of adjuvant therapy in human papillomavirus-positive oropharyngeal cancer.

Young Min Park,Jae-Yol Lim,Yoon Woo Koh,Eun Chang Choi,Se-Heon Kim

Head & neck（2023）

引用 0|浏览22

暂无评分

摘要

In T1-T2 lesions without other risk factors, even with a safety margin ≥1 mm, adjuvant therapy can potentially be omitted. Adjuvant therapy can significantly reduce disease recurrence in HPV+ OPSCC patients with risk factors.

查看译文

关键词

adjuvant therapy, HPV-positive oropharyngeal cancer, neoadjuvant chemotherapy, safety margin

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要